Drug Labeling and Warnings

Drug Details [pdf]

SILKA ANTIFUNGAL FOOT- miconazole nitrate powder 
Genomma Lab

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Active Ingredient

Miconazole Nitrate 2%

Purpose

Antifungal

Uses

For the cure of most athlete's foot.

Warnings

For external use only.

Do not use on children of 2 years of age unless directed by a doctor.

When using this product avoid contact with eyes.

Stop use and ask a doctor if irritation occurs or there is no improvement within 4 weeks.

Keep Out of Reach of Children.

If swallowed, seek medical help or contact a Poison Control Center right away.

Directions

  • Clean the affected area and dry thoroughly.
  • Apply a thin layer of the product over the affected area twice daily (morning and night) or as directed by a doctor.
  • Supervise children in the use of this product.
  • Pay special attention to space between the toes; wear well-fitting, ventilated shoes and change socks at least once daily.
  • Use daily for 4 weeks.
  • If condition persists longer, consult a doctor.
  • This product is not effective on scalp and nails.

Inactive Ingredients

Aldioxa, Cellulose, Chloroxylenol, Fragrance, Imidazolidynl Urea, Talc.

Front LabelBack Label

SILKA ANTIFUNGAL FOOT 
miconazole nitrate powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 50066-277
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MICONAZOLE NITRATE (UNII: VW4H1CYW1K) (MICONAZOLE - UNII:7NNO0D7S5M) MICONAZOLE NITRATE2 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
ALPHA CELLULOSE (UNII: I355QGZ19A)  
CHLOROXYLENOL (UNII: 0F32U78V2Q)  
IMIDUREA (UNII: M629807ATL)  
TALC (UNII: 7SEV7J4R1U)  
ALDIOXA (UNII: 8T66I31YNK)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 50066-277-0385 g in 1 BOTTLE; Type 0: Not a Combination Product08/09/201802/03/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333C08/09/201802/03/2020
Labeler - Genomma Lab (832323534)
Registrant - Derma Care Research Labs (116817470)
Establishment
NameAddressID/FEIBusiness Operations
Derma Care Research labs116817470manufacture(50066-277)

Revised: 10/2022
 

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.